Acute StrokeTreatment in Children: Are Adult Guidelines Applicable?

Sudeepta Dandapat1, Waldo R Guerrero2, Santiago Ortega-Gutierrez3

  • 1Department of Neurosciences, Aurora Neuroscience Innovation Institute, St.Luke's Hospital, Milwaukee, WI.

Insights

Acute stroke treatments for adults are being adapted for children. Advances in imaging and therapies like endovascular therapy aim to improve outcomes for pediatric arterial ischemic stroke, a significant cause of childhood disability.

Area of Science:

  • Pediatric Neurology
  • Cerebrovascular Diseases
  • Acute Stroke Management

Background:

  • Pediatric arterial ischemic stroke (AIS) is a critical cause of long-term disability and mortality in children.
  • Diagnosing and treating pediatric AIS presents unique age-dependent challenges compared to adults.
  • Recent advancements in diagnostic imaging and acute stroke interventions are improving management.

Purpose of the Study:

  • To review current acute stroke treatments established in adults for their applicability in pediatric populations.
  • To highlight advancements in hyperacute stroke therapies for children.
  • To emphasize the importance of understanding pediatric stroke for better patient outcomes.

Main Methods:

  • Review of existing literature on adult acute stroke treatments.
  • Analysis of applicability and adaptation of these treatments for pediatric patients.
  • Discussion of recent advancements in pediatric stroke diagnosis and management.

Main Results:

  • Adult acute stroke treatments are increasingly being evaluated and applied to pediatric cases.
  • Hyperacute treatments, including endovascular therapy, show promise for improving pediatric stroke outcomes.
  • Improved diagnostic tools and expanded treatment windows enhance the management of pediatric arterial ischemic disease.

Conclusions:

  • Adapting adult stroke protocols and validating pediatric-specific pathways are crucial for advancing acute stroke care in children.
  • Early and effective intervention is vital, given the potentially greater lifelong burden of disability in pediatric stroke survivors.
  • Knowledge of available medical and therapeutic options is essential for managing this unique patient population.
Abstract